U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Blood Grouping Reagent, Anti-B (Murine Monoclonal) (IgG) (Formulated for Automated Testing)
  1. Blood & Blood Products

Blood Grouping Reagent, Anti-B (Murine Monoclonal) (IgG) (Formulated for Automated Testing)

STN#: 125532
Proper Name: Blood Grouping Reagent, Anti-B (Murine Monoclonal) (IgG) (Formulated for Automated Testing)
Tradename:  IH-Card
Manufacturer: Bio-Rad Medical Diagnostics GmbH
Indication:

  • The IH-Card ABO/D(DVI+)+Rev A1, B is intended for the performance of forward and reverse ABO grouping and D (RH1) antigen typing of human red blood samples using the IH-System.
  • The IH-Card ABD(DVI+)-Conf is intended for the detection of A (ABO1), B (ABO2) and D (RH1) antigens on human red blood cells using the IH-System.
  • The IH-Card Group ABO is intended for the detection of A (ABO1) and B (ABO2) antigens on human red blood cells using the IH-System.
  • The IH-Card ABO/RhD (DVI+) is intended for the detection of A (ABO1), B (ABO2) and D (RH1) antigens on human red blood cells and for the detection of immunoglobulins and complement on human red blood cells using the Direct Antiglobulin Test using the IH-System.
  • The IH-Card ABO/D(DVI-)+Rev A1, B is intended for the performance of forward and reverse ABO grouping and D (RH1) antigen typing of human red blood samples using the IH-System.
  • The IH-Card ABD(DVI-)-Conf is intended for the detection of A (ABO1) and B (ABO2) and D (RH1) antigens on human red blood cells using the IH-System.

Product Information

Supporting Documents

Back to Top